MX2009014126A - Pirenzepina y derivados de la misma como agentes anti-amiloides. - Google Patents
Pirenzepina y derivados de la misma como agentes anti-amiloides.Info
- Publication number
- MX2009014126A MX2009014126A MX2009014126A MX2009014126A MX2009014126A MX 2009014126 A MX2009014126 A MX 2009014126A MX 2009014126 A MX2009014126 A MX 2009014126A MX 2009014126 A MX2009014126 A MX 2009014126A MX 2009014126 A MX2009014126 A MX 2009014126A
- Authority
- MX
- Mexico
- Prior art keywords
- therapeutic compound
- relates
- compound
- amyloid
- retarding
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 3
- 230000001225 therapeutic effect Effects 0.000 title 1
- 208000037259 Amyloid Plaque Diseases 0.000 abstract 2
- 241000124008 Mammalia Species 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 210000004556 brain Anatomy 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 239000002207 metabolite Substances 0.000 abstract 1
- 230000000979 retarding effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Diabetes (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Virology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Emergency Medicine (AREA)
- Communicable Diseases (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Psychiatry (AREA)
- Ophthalmology & Optometry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP07111491 | 2007-07-02 | ||
| PCT/EP2008/058527 WO2009004038A2 (en) | 2007-07-02 | 2008-07-02 | Therapeutic compound |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2009014126A true MX2009014126A (es) | 2010-03-29 |
Family
ID=40020257
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2009014126A MX2009014126A (es) | 2007-07-02 | 2008-07-02 | Pirenzepina y derivados de la misma como agentes anti-amiloides. |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20100247688A1 (enExample) |
| EP (1) | EP2173355A2 (enExample) |
| JP (1) | JP2010531854A (enExample) |
| KR (1) | KR20100038424A (enExample) |
| CN (1) | CN101778634A (enExample) |
| AU (1) | AU2008270247A1 (enExample) |
| BR (1) | BRPI0812849A2 (enExample) |
| CA (1) | CA2691844A1 (enExample) |
| IL (1) | IL202768A0 (enExample) |
| MX (1) | MX2009014126A (enExample) |
| NZ (1) | NZ582314A (enExample) |
| RU (1) | RU2010103105A (enExample) |
| WO (1) | WO2009004038A2 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010081823A1 (en) | 2009-01-13 | 2010-07-22 | Proteosys Ag | Pirenzepine as otoprotective agent |
| US9453021B2 (en) | 2011-05-10 | 2016-09-27 | Kyowa Hakko Kirin Co., Ltd. | Pyrimidodiazepinone compound |
| WO2013068592A1 (en) * | 2011-11-10 | 2013-05-16 | Fondation Jerome Lejeune | Inhibitors of cystathionine beta synthase to reduce the neurotoxic overproduction of endogenous hydrogen sulfide |
| CN116635034A (zh) * | 2020-09-22 | 2023-08-22 | K·E·克拉伦斯-史密斯 | 用于治疗人低胆碱能障碍的药物组合 |
| EP4217063A4 (en) * | 2020-09-22 | 2024-10-30 | Kathleen E. Clarence-Smith | PHARMACEUTICAL COMBINATION FOR THE TREATMENT OF HUMAN HYPOCHOLINERGIC DISORDERS |
| KR20240163606A (ko) * | 2022-01-16 | 2024-11-19 | 윈산토르, 아이엔씨. | 성적 감각 장애를 개선하기 위한 조성물 및 방법 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1795183B1 (de) * | 1968-08-20 | 1972-07-20 | Thomae Gmbh Dr K | 5,11-Dihydro-6H-pyrido[2,3-b][1,4]benzodiazepin-6-on-derivate und Arzneimittel |
| DE3818299A1 (de) * | 1988-05-30 | 1989-12-07 | Thomae Gmbh Dr K | Neue kondensierte diazepinone, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
| DE4112014A1 (de) * | 1991-04-12 | 1992-10-15 | Thomae Gmbh Dr K | Kondensierte diazepinone, verfahren zu ihrer herstellung und diese verbindungen enthaltende mittel zur behandlung von erkrankungen des zentralnervensystems und zur foerderung der cerebralen durchblutung |
| US8039464B2 (en) * | 2004-07-16 | 2011-10-18 | Proteosys Ag | Muscarinic antagonists with PARP and SIR modulating activity as agents for inflammatory diseases |
| US7994160B2 (en) * | 2005-07-12 | 2011-08-09 | Abbott Gmbh & Co. Kg | Pyridazine compounds as glycogen synthase kinase 3 inhibitors |
-
2008
- 2008-07-02 NZ NZ582314A patent/NZ582314A/en not_active IP Right Cessation
- 2008-07-02 EP EP08774661A patent/EP2173355A2/en not_active Withdrawn
- 2008-07-02 CA CA002691844A patent/CA2691844A1/en not_active Abandoned
- 2008-07-02 BR BRPI0812849-9A2A patent/BRPI0812849A2/pt not_active IP Right Cessation
- 2008-07-02 AU AU2008270247A patent/AU2008270247A1/en not_active Abandoned
- 2008-07-02 MX MX2009014126A patent/MX2009014126A/es not_active Application Discontinuation
- 2008-07-02 US US12/667,445 patent/US20100247688A1/en not_active Abandoned
- 2008-07-02 JP JP2010513980A patent/JP2010531854A/ja not_active Withdrawn
- 2008-07-02 RU RU2010103105/15A patent/RU2010103105A/ru not_active Application Discontinuation
- 2008-07-02 CN CN200880103247A patent/CN101778634A/zh active Pending
- 2008-07-02 WO PCT/EP2008/058527 patent/WO2009004038A2/en not_active Ceased
- 2008-07-02 KR KR1020107002421A patent/KR20100038424A/ko not_active Withdrawn
-
2009
- 2009-12-16 IL IL202768A patent/IL202768A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NZ582314A (en) | 2012-04-27 |
| US20100247688A1 (en) | 2010-09-30 |
| KR20100038424A (ko) | 2010-04-14 |
| AU2008270247A2 (en) | 2010-01-28 |
| BRPI0812849A2 (pt) | 2014-12-09 |
| IL202768A0 (en) | 2010-06-30 |
| EP2173355A2 (en) | 2010-04-14 |
| WO2009004038A8 (en) | 2010-03-11 |
| JP2010531854A (ja) | 2010-09-30 |
| CN101778634A (zh) | 2010-07-14 |
| RU2010103105A (ru) | 2011-08-10 |
| WO2009004038A2 (en) | 2009-01-08 |
| AU2008270247A1 (en) | 2009-01-08 |
| WO2009004038A3 (en) | 2009-11-26 |
| CA2691844A1 (en) | 2009-01-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG179418A1 (en) | Inhibitors of the hedgehog pathway | |
| MX2008010931A (es) | Quinolonas utiles como inhibidores de sintasa de oxido nitrico inducibles. | |
| TW200612958A (en) | Substituted imidazole derivatives | |
| TW200626610A (en) | Analogs of 17-hydroxywortmannin as PI3K inhibitors | |
| IN2014DN05772A (enExample) | ||
| TW201000473A (en) | Benzene or thiophene derivative and use thereof as VAP-1 inhibitor | |
| WO2009016460A8 (en) | Pyrazole compounds and their use as raf inhibitors | |
| CA2818187C (en) | Bromodomain inhibitors and uses thereof | |
| GEP201606532B (en) | Benzamide derivatives for inhibiting the activity of abl1, abl2 and bcr-abl1 | |
| MY148657A (en) | Trpv1 antagonists and uses thereof | |
| WO2011039735A3 (en) | Compounds with ddx3 inhibitory activity and uses thereof | |
| TN2011000291A1 (en) | Purine compounds | |
| PT2323972E (pt) | Compostos de tetraciclina substituídos com c7-flúor | |
| IL198901A0 (en) | Pyrimidine derivatives and multiple myeloma | |
| GEP20125708B (en) | Hydroxamate-based inhibitors of deacetylases b | |
| MX2009014126A (es) | Pirenzepina y derivados de la misma como agentes anti-amiloides. | |
| MX2011009493A (es) | Compuestos para el tratamiento de trastornos metabolicos. | |
| IN2012DN00695A (enExample) | ||
| MX2012001617A (es) | Derivados de 5-fluoro-2-oxopirimidina-1 (2h)-carboxamida substituida-n1. | |
| MX2010001300A (es) | Uso de hesperidina o un derivado de la misma para prevencion y/o tratamiento de pieles flacidas. | |
| NZ613085A (en) | Thiosemicarbazone compounds and use in the treatment of cancer | |
| EP1962839A4 (en) | ADMINISTRATION OF A MNTOR INHIBITOR FOR THE TREATMENT OF PATIENTS WITH CANCER | |
| MY147188A (en) | Substituted imidazole compounds as ksp inhibitors | |
| UA109793C2 (uk) | Арилсульфонаміди для лікування захворювань центральної нервової системи (цнс) | |
| MX2011012522A (es) | Inhibidores de pirazol sustituido de proteina cinasa c-met. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| HH | Correction or change in general | ||
| FA | Abandonment or withdrawal |